- Trim Your Holiday Stress This Season: Experts Offer Tips
- Identical Twins Study Shows Vegan Diets Helping the Heart
- Your Personality Might Help Shield You From Dementia
- Couch Potatoes, ‘Squatting Breaks’ Could Keep Your Mind Sharp
- As Salmonella Outbreak Widens, Avoid Cantaloupes if Brand Is Unknown, CDC Warns
- Persistent Inflammation Could Drive Brain Issues in Former Football Players
- Watch or Remove? Study Finds One Option May Be Better for Abnormal Cervical Lesions
- Treatment Used on Donated Hearts May Be Useless, Even Harmful: Study
- Baseball Puts Kids’ Elbows at Risk, Study Shows
- U.S. Gun Suicides Keep Rising; Now Make Up Half of All Suicides
Stent to Treat Pancreatic Cysts Approved

The Axios Stent and Delivery System has been approved by the U.S. Food and Drug Administration to treat infected pancreatic cysts that won’t drain on their own and could become life threatening, the FDA said in a news release.
The pancreas, found in the upper abdomen behind the stomach, produces insulin that helps regulate blood sugar and helps digestion. If pancreatic ducts become blocked from gallstones or injury, enzymes that back up into the organ can cause formation of pancreatic pseudocysts.
Most resolve on their own, but some become infected and can lead to a life-threatening blood infection, the FDA said.
The Axios stent is a wire mesh tube that can expand to more than 1/2-inch diameter. It was evaluated among 33 clinical study participants who had a pancreatic pseudocyst at least six centimeters in diameter. Some 86 percent of pseudocysts treated shrank by half or more, the FDA said.
The most common side effects of the stent included abdominal pain, nausea and vomiting.
The device is produced by Xlumena Inc. of Mountain View, Calif.
More information
Visit Medline Plus to learn more about pancreatic pseudocysts.
Source: HealthDay
Copyright © 2023 HealthDay. All rights reserved.